Related Experiment Video
Updated: Mar 9, 2026
07:16
Thermal Ablation for the Treatment of Abdominal Tumors
Published on: March 7, 2011
35.2K
Percutaneous imaging-guided cryoablation for lung cancer
Yi-Shi Zhang1, Li-Zhi Niu1, Ke Zhan2
1Department of Oncology, Fuda Cancer Hospital, Jinan University School of Medicene, Guangzhou 510665, China.
Journal of Thoracic Disease
|January 10, 2017
Summary
Percutaneous cryoablation is a safe and effective lung cancer treatment, offering high local tumor control. This minimally invasive technique is suitable for various disease stages, including early-stage pure ground-glass nodules.
Area of Science:
- Oncology
- Interventional Radiology
- Pulmonology
Background:
- Lung cancer remains a leading cause of cancer-related mortality worldwide.
- Minimally invasive treatment options are crucial for improving patient outcomes and reducing morbidity.
- Percutaneous cryoablation offers a targeted approach for tumor destruction.
Approach:
- This review summarizes the technique and mechanism of percutaneous cryoablation.
- It analyzes studies on cryoablation for various stages of lung cancer.
- The emerging application in treating pure ground-glass nodules (GGNs) is also discussed.
Key Points:
- Percutaneous cryoablation demonstrates a high local tumor control rate in lung cancer.
- Complications associated with cryoablation are generally manageable.
- The procedure is effective for both radical cure and palliation across different disease stages.
Conclusions:
- Percutaneous cryoablation is a safe and effective treatment modality for lung cancer.
- It represents a reasonable therapeutic choice, particularly for its high local control rates and manageable complications.
- Its utility extends to early-stage lung cancers, including pure ground-glass nodules.
